Type 2 diabetes

October 14, 2009 -- WASHINGTON, D.C. - Senator Tom Harkin (D-IA), Chairman of the Health, Education, Labor and Pensions (HELP) Committee, today applauded a study that shows that people who live in “healthy neighborhoods,” or neighborhoods with safe sidewalks, parks, public transportation and access to fresh fruits and vegetables, are 38 percent less likely to develop diabetes than people who live in less healthy neighborhoods. Diabetes is estimated to account for over $116 billion in medical costs in the U.S. each year.    » read more »

June 7, 2009, London UK -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria® (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing.1 Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.2    » read more »

10/02/2007 -- Washington Nationals first baseman Dmitri Young today was named the recipient of the National League Comeback Player of the Year Award. The Comeback Player of the Year Award is officially sanctioned by Major League Baseball, and is presented annually to one player in each league who has re-emerged on the baseball field during the season.    » read more »

30 September 2007 -- The World Heart Federation says heart disease and stroke are the world's largest killers, claiming 17.5 million lives a year. Marking World Heart Day, the Federation says knowing the risk factors and leading a healthy active lifestyle can largely prevent people from getting these chronic, ultimately fatal diseases.

The World Heart Federation says heart disease and stroke are commonly believed to be diseases of the wealthy. But studies show 80 percent of all deaths from these chronic illnesses occur in low and middle-income countries.    » read more »

A Second Exploratory Study Comparing Exubera and Lantus Assessed Daily Blood Sugar Levels in Patients with Type 2 Diabetes

- One-Year Data Showed Investigational Use of Initial Combination Therapy with JANUVIA™ (sitagliptin) and Metformin Significantly Improved Blood Sugar Control in Patients with Type 2 Diabetes Compared to Metformin Alone
- Data Also Showed that Initial Combination Therapy with JANUVIA and Metformin Led to Significant Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

St. Louis, Sept. 6, 2007 — Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis.

This study, performed in mice, suggests that Metformin, the most commonly prescribed anti-diabetes drug, could potentially improve pregnancy outcomes in women with insulin resistance.    » read more »